“…Of the 17 articles, 4 (24%) were published in Norway [25][26][27][28], and 3 (18%) were published in Spain [29][30][31], followed by China (n=3, 18%) [32][33][34], Singapore (n=2, 12%) [35,36], the United States (n=1, 6%) [37], Australia (n=1, 6%) [38], France (n=1, 6%) [39], the United Kingdom (n=1, 6%) [40], and Israel (n=1, 6%) [41]. A total of 35% (6/17) of the studies were multicenter randomized controlled trials (RCTs) [25,26,32,33,37,38], 29% (5/17) were single-center RCTs [29,34,36,40,41], 6% (1/17) were non-RCTs [30], 6% (1/17) had an experimental design [31], 18% (3/17) were qualitative studies [27,28,39], and 6% (1/17) had a mixed methods design [35]. The study interventions included a web-based telemedicine system [30][31][32][33][37][38][39], web-based applications [29,35,36,…”